High response rate to PD-1 blockade in desmoplastic melanomas

Zeynep Eroglu; Jesse M. Zaretsky; Siwen Hu‐Lieskovan; Dae Won Kim; Alain P. Algazi; Douglas B. Johnson; Elizabeth Liniker; Benjamin Y. Kong; Rodrigo Ramella Munhoz; Suthee Rapisuwon; Pier Federico Gherardini; Bartosz Chmielowski; Xiaoyan Wang; I. Peter Shintaku; Cody Wei; Jeffrey A. Sosman; Richard W. Joseph; Michael A. Postow; Matteo S. Carlino; Wen-Jen Hwu; Richard A Scolyer; Jane L. Messina; Alistair J. Cochran; Georgina V. Long; Antoni Ribas

doi:10.1038/nature25187

Related publications

Article2017

Analysis of mutational burden and adaptive immune response in desmoplastic melanomas treated with PD-1/L1 inhibitors.

Siwen Hu‐Lieskovan, Zeynep Eroglu, Jesse M. Zaretsky, Dae Won Kim, Alain P. Algazi, Douglas B. Johnson, Elizabeth Liniker, Ben L. Kong, Rodrigo Ramella Munhoz, Suthee Rapisuwon, Bartosz Chmielowski, Jeffrey A. Sosman, Richard A Scolyer, Richard W. Joseph, Michael A. Postow, Matteo S. Carlino, Wen‐Jen Hwu, Georgina V. Long, Antoni Ribas

Article2023

Definitive treatment with PD-1 blockade and radiation therapy of unresected primary desmoplastic melanoma of the nose

Caroline A. Gjorup, Inês Pires da Silva, Linda K. Martin, Jonathan R. Stretch, Richard A Scolyer, Georgina V. Long, Angela Hong

Article2021

PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma

Sagun Parakh, Ashan Musafer, Sabrina Paessler, Tom Witkowski, Connie S.N. Li Wai Suen, Candani Tutuka, Matteo S. Carlino, Alexander M. Menzies, Richard A Scolyer, Jonathan Cebon, Alexander Dobrovic, Georgina V. Long, Oliver Klein, Andreas Behren

Article2017

Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma

Ricardo E. Vilain, Alexander M. Menzies, James S. Wilmott, Hojabr Kakavand, Jason Madore, Alexander Guminski, Elizabeth Liniker, Benjamin Y. Kong, Adam Cooper, Julie R. Howle, Robyn P.M. Saw, Valerie Jakrot, Serigne Lo, John F. Thompson, Matteo S. Carlino, Richard Kefford, Georgina V. Long, Richard A Scolyer

Article2022

Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade

Jiao Liu, Rui Kang, Guido Guido Kroemer, Daolin Tang